1. Home
  2. COCP vs FEAM Comparison

COCP vs FEAM Comparison

Compare COCP & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • FEAM
  • Stock Information
  • Founded
  • COCP 2006
  • FEAM 2016
  • Country
  • COCP United States
  • FEAM United States
  • Employees
  • COCP N/A
  • FEAM N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • COCP Health Care
  • FEAM Industrials
  • Exchange
  • COCP Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • COCP 15.3M
  • FEAM 12.8M
  • IPO Year
  • COCP N/A
  • FEAM N/A
  • Fundamental
  • Price
  • COCP $1.60
  • FEAM $4.64
  • Analyst Decision
  • COCP Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • COCP 1
  • FEAM 2
  • Target Price
  • COCP $7.00
  • FEAM $121.00
  • AVG Volume (30 Days)
  • COCP 17.1K
  • FEAM 13.3K
  • Earning Date
  • COCP 05-12-2025
  • FEAM 05-13-2025
  • Dividend Yield
  • COCP N/A
  • FEAM N/A
  • EPS Growth
  • COCP N/A
  • FEAM N/A
  • EPS
  • COCP N/A
  • FEAM N/A
  • Revenue
  • COCP N/A
  • FEAM N/A
  • Revenue This Year
  • COCP N/A
  • FEAM N/A
  • Revenue Next Year
  • COCP N/A
  • FEAM N/A
  • P/E Ratio
  • COCP N/A
  • FEAM N/A
  • Revenue Growth
  • COCP N/A
  • FEAM N/A
  • 52 Week Low
  • COCP $1.12
  • FEAM $2.82
  • 52 Week High
  • COCP $3.26
  • FEAM $45.89
  • Technical
  • Relative Strength Index (RSI)
  • COCP 57.48
  • FEAM 52.34
  • Support Level
  • COCP $1.49
  • FEAM $4.30
  • Resistance Level
  • COCP $1.74
  • FEAM $5.22
  • Average True Range (ATR)
  • COCP 0.15
  • FEAM 0.42
  • MACD
  • COCP 0.04
  • FEAM 0.04
  • Stochastic Oscillator
  • COCP 63.79
  • FEAM 60.41

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: